Advanced Cell Technology and Curis Show Strong Growth Potential
The Bedford Report Provides Analyst Research on Advanced Cell Technology & Curis
Companies:Advanced Cell Technology Inc.Curis Inc.
Symbol Price Change
ACTC.OB 0.18 0.00
Follow these stocks
Press Release Source: The Bedford Report On Thursday April 28, 2011, 8:16 am
NEW YORK, NY--(Marketwire - 04/28/11) - There
This email is compliments of Scottrade.com
If you would like to modify or suspend this alert, please login to your Scottrade account and navigate to the "Alerts" page under the "My Account" tab.
News for 'ACTC' - (ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2 Clinical Trials using hESC-Derived RPE Cells for the Treatment of Macular Degeneration UCLA's Jules Stein Eye Institute to be a Site for Phase 1/2 Trials for Stargardt's Macular Dystrophy (SMD)
Copyright © 2012 InvestorStemcell.com - All Rights ReservedContent Relevant URLs by vBSEO 3.6.0 PL2
Website built by: Relivo Media